Age group at IMD (years) | Group | Time between HIV and IMD diagnosis | Time between ART and IMD | CD4 <350 cells/mm3 at HIV diagnosis | CD4 at IMD <350 cells/mm3 | HIV risk | Region of birth | Year of arrival | Clinical presentation | ICU admission |
---|---|---|---|---|---|---|---|---|---|---|
<16 | B | 2Â years | 2Â years | N | N | MTCT | Africa | 2008 | Septicaemia | N |
16–24 | W | 13 years | - | N/A | N/A | MTCT | Africa | 2000 | Pneumonia | Y |
16–24 | B | After IMD | After IMD | Y | N/A | MSM | Asia | 2008 | Men & Sep | Y |
16–24 | Y | 2 years | 2 years | Y | N | HET | Africa | 2004 | Men & Sep | Y |
25–44 | Y | 11 years | 11 years | Y | Y | HET | Africa | 2002 | Septic arthritis | N |
25–44 | C | 9 years | 9 years | N | N | HET | Africa | 2000 | Septicaemia | N |
25–44 | W | 8 years | 8 years | N | N | HET | Africa | 2004 | Septicaemia | Y |
25–44 | B | 5 years | 4 years | Y | Y | HET | Africa | 2004 | Septicaemia | N |
45–64 | C | 5 years | At time of IMD | N | N/A | MSM | UK | - | Septicaemia | N |
45–64 | Y | 16 years | 2 years | N | Y | HET | UK | - | Pneumonia | N |
45–64 | Y | 10 years | At time of IMD | Y | N/A | HET | Africa | 1988 | Septicaemia | Y |
45–64 | B | 3 years | 3 years | Y | Y | HET | Africa | 2002 | Meningitis | N |
45–64 | Y | At the time of IMD | After IMD | N | N | HET | Africa | 1975 | Men & Sep | Y |
45–64 | C | At the time of IMD | Not on ART | Y | Y | HET | UK | - | Septicaemia | N |